Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 156 recruiting now early-phase tilt #40 of 28,707 conditions

Opioid Use Disorder: early-phase trial registry

156 of 258 indexed Opioid Use Disorder trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #40 of 28,707 conditions by registered trial count.

258 US clinical trials · 156 currently recruiting · #40 of 28,707 conditions by registered trial count

Opioid Use Disorder: 258 US clinical trials tracked, 156 recruiting.

Opioid Use Disorder is the subject of 258 registered US clinical trials on ClinicalTrials.gov, 156 of them currently open to new participants. 23 are in Phase 3-4 (later-stage) and 59 in Phase 1-2 (earlier-stage). The most active sponsor is Yale University, running 19 of these trials.

Enrollment posture brief

Registry condition opioid-use-disorder

OPEN 156 | RECR 60% | LATE 23 | EARLY 59 | RANK #40 | SPON 19

Nearest open-share peer: HIV Prevention (61% recruiting · 33 trials)

Opioid Use Disorder (this)60%Aging47.9%Post Traumatic Stress Disord41.5%Head and Neck Cancer34.2%Melanoma33.1%
Open-enrollment share among volume-matched conditions near Opioid Use Disorder

Opioid Use Disorder lists 156 open slots (60% of 258 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Opioid Use Disorder on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Opioid Use Disorder is recruiting above its size-band peers.

    156 of 258 indexed trials (60.5%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Opioid Use Disorder trials is spread across many organizations.

    Yale University accounts for 19 of 258 trials (7.4%). 127 distinct sponsors appear on at least one study for this condition label.

  3. Typical Opioid Use Disorder enrolment sits around 103 participants.

    Median target enrolment is 103 among the 258 trials that report a genuine target (sentinel values excluded). 121 of those (46.9%) plan for fewer than 100 participants.

  4. Opioid Use Disorder research is mostly interventional.

    233 interventional and 25 observational studies make up this index (90.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 127Phase 232Phase 312Phase 411

Phase Distribution

PhaseTrial count
Phase 1 27
Phase 2 32
Phase 3 12
Phase 4 11

Named interventions

Most-linked intervention names on Opioid Use Disorder records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
13 trials
Buprenorphine Drug
5 trials
Psilocybin Drug
4 trials
Usual Care Behavioral
4 trials
Lofexidine Drug
3 trials
Contingency Management Behavioral
3 trials
Treatment as Usual (TAU) Behavioral
3 trials
Methadone Drug
3 trials

US sites by state

Facility locations filed on Opioid Use Disorder trials. A trial with sites in several states counts in each.

Pennsylvania 40 trials
Massachusetts 30 trials
New York 29 trials
California 29 trials
Maryland 26 trials
Connecticut 20 trials
Ohio 15 trials
New Jersey 15 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Opioid Use Disorder page

258 registered trials, 156 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 156 Opioid Use Disorder trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Yale University sponsors the most Opioid Use Disorder trials on record, review their full trial history before evaluating a specific study. See Yale University's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Opioid Use Disorder condition card totals 258 registered trials; most-linked intervention Placebo; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.